Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Rethinking the burden of latent tuberculosis to reprioritize research

Nature Microbiology (2024)Cite this article

Subjects

Analyses refuting the dogma that a quarter of the world’s population is latently infected with Mycobacterium tuberculosis emphasize the need for a redirection of research priorities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Models of TB pathogenesis and disease progression.

References

  1. Behr, M. A., Edelstein, P. H. & Ramakrishnan, L. Br. Med. J. 362, k2738 (2018).

    Article  Google Scholar 

  2. Global Tuberculosis Report 2021 (WHO, 2021); https://go.nature.com/3re4n6j

  3. Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis M72 Vaccine Candidate That Could Be the First in 100 Years if Proven Effective (Bill & Melinda Gates Foundation, 2023); https://go.nature.com/3VVlv8L

  4. Nat. Microbiol. 8, 1601–1602 (2023).

  5. Tozer, L. Nature https://doi.org/10.1038/d41586-023-02171-x (2023).

  6. Behr, M. A., Edelstein, P. H. & Ramakrishnan, L. Br. Med. J. 367, l5770 (2019).

    Article  Google Scholar 

  7. Emery, J. C. et al. Proc. R. Soc. B 288, 20201635 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Global Tuberculosis Report 2023 (WHO, 2023); https://go.nature.com/3PW21Nk

  9. Divangahi, M., Khan, N. & Kaufmann, E. Front. Immunol. 9, 2976 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Roy Chowdhury, R. et al. Nature 560, 644–648 (2018).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

M.A.B. is supported by a Tier 1 Canada Research Chair from the Canadian Institutes for Health Research. L.R. is supported by a Principal Research Fellowship from the Wellcome Trust and a Research Project Grant (RO1) from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Department of Medicine, McGill University, McGill International TB Centre, Montreal, Quebec, Canada

    Marcel A. Behr

  2. Department of Medicine, University of Cambridge, Cambridge, UK

    Paul H. Edelstein & Lalita Ramakrishnan

  3. MRC Laboratory of Molecular Biology, Cambridge, UK

    Paul H. Edelstein & Lalita Ramakrishnan

Authors
  1. Marcel A. Behr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul H. Edelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lalita Ramakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lalita Ramakrishnan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Microbiology thanks Brian Robertson and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Behr, M.A., Edelstein, P.H. & Ramakrishnan, L. Rethinking the burden of latent tuberculosis to reprioritize research. Nat Microbiol (2024). https://doi.org/10.1038/s41564-024-01683-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41564-024-01683-0

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology